Edited by: Eugene Russo
T CELL STARTER: Harvard's Michael Grusby believes that research on Stat pathways will lead to a better understanding of T cell differentiation.
Comments by Michael J. Grusby, Department of Immunology and Infectious Diseases, Harvard School of Public Health
Sometimes good cells turn bad. When produced at the wrong time, T helper cells, which are meant to fight off harmful antigens, can end up attacking the molecules, cells, and tissues that they're suppose to be defending, thereby causing autoimmune diseases. Potential therapies for such disorders may entail the manipulation of the cell pathways that lead to T helper cell differentiation. Scientists have attempted to do so by identifying the...
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?